Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches

13 Sept 2007

Abstract excerpt

Chimeric 101F (ch101F) is a mouse-human chimeric anti-human respiratory syncytial virus (HRSV) neutralizing antibody that recognizes residues within antigenic site IV, V, VI of the fusion (F) glycoprotein. The binding of ch101F to a series of peptides overlapping aa 422-438 spanning antigenic site IV, V, VI was analysed. Residues 423-436 comprise the minimal peptide sequence for ch101F binding. Substitution...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Respiratory viral infections research
Share to Viral gastroenteritis research and epidemiology
Share to Virology and Viral Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17872524
DOI: 10.1099/vir.0.82753-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approachesPMID 17872524Read ↗

Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virusSemantic proximity Read ↗

Relationship between the loss of neutralizing antibody binding and fusion activity of the F protein of human respiratory syncytial virus.Semantic proximity Read ↗

Antigenic Structure of Human Respiratory Syncytial Virus Fusion GlycoproteinSemantic proximity Read ↗

Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.Semantic proximity Read ↗

Comparison of human respiratory syncytial virus A2 and 8/60 fusion glycoprotein gene sequences and mapping of sub-group specific antibody epitopes.Semantic proximity Read ↗

Computational redesign of human respiratory syncytial virus epitope as therapeutic peptide vaccines against pediatric pneumonia.Semantic proximity Read ↗

Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion proteinSemantic proximity Read ↗

Development of human single-chain antibodies against SARS-associated coronavirus.Semantic proximity Read ↗

Antigenic and sequence variability of the human respiratory syncytial virus F glycoprotein compared to related viruses in a comprehensive datasetSemantic proximity Read ↗

Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus.Semantic proximity Read ↗

Recognition by Human Monoclonal Antibodies of Free and Complexed Peptides Representing the Prefusogenic and Fusogenic Forms of Human Immunodeficiency Virus Type 1 gp41Semantic proximity Read ↗

Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.